LRP1 and central nervous system cancer: LRP1 is widely expressed in human and mouse BCECs [18] and gliomas [38], making angiopep-2 an attractive targeting moiety for various nanoparticles for brain delivery and glioma targeting [39,40,41,42,43,44,45,46,47].